Trulicity provides reliable results with a longer track record and potentially easier insurance coverage
Lammi, C
Guan YY, Liu HJ, Luan X, Xu JR, Lu Q, Liu YR, et al
25 Easing prices Looking down the road at possible costs, there are grounds for optimism
Patients who lose 15% of their body weight on tirzepatide and later transition to Retatrutide may achieve additional loss, potentially reaching the 25% to 30% range overall
Understanding your genetic predispositions can support a more informed conversation with your provider about expected dosing response, potential side effect susceptibility, and whether maximum-dose escalation aligns with your individual physiology